Cargando…
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
OBJECTIVE: The efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is controversial. The aim of this study was to estimate the efficacy of adalimumab in these patients and to identify the factors predicting succ...
Autores principales: | Bouhnik, Yoram, Carbonnel, Franck, Laharie, David, Stefanescu, Carmen, Hébuterne, Xavier, Abitbol, Vered, Nachury, Maria, Brixi, Hedia, Bourreille, Arnaud, Picon, Laurence, Bourrier, Anne, Allez, Matthieu, Peyrin-Biroulet, Laurent, Moreau, Jacques, Savoye, Guillaume, Fumery, Mathurin, Nancey, Stephane, Roblin, Xavier, Altwegg, Romain, Bouguen, Guillaume, Bommelaer, Gilles, Danese, Silvio, Louis, Edouard, Zappa, Magaly, Mary, Jean-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754855/ https://www.ncbi.nlm.nih.gov/pubmed/28119352 http://dx.doi.org/10.1136/gutjnl-2016-312581 |
Ejemplares similares
-
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Rayer, Cassandra, et al.
Publicado: (2023) -
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Cassandra, Rayer, et al.
Publicado: (2022) -
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021) -
Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
por: Vuitton, Lucine, et al.
Publicado: (2022) -
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)